A GIS Approach to Staphylococcus Associated Mortality in Texas in 2005 By Samuel F. Barker, MT School of Rural Public Health Texas A&M Health Science Center Refer all questions to:
Updates and Assumptions Oxacillin, Nafcillin, and Methicillin were treated equally to establish methicillin resistance. By definition, MRSA is genetically resistant to: Betalactams Cephalosporins Carbapenems Intermediate resistance was treated as resistant based on clinical treatment protocols.
Texas Death Cohort ,924 deaths on record 439 records listed Staphylococcus sp. as a contributing cause 223 records listed Staphylococcus sp. as the underlying cause 210 records requested 114 complete records received
Texas Staphylococcal Death Cases in 2005
Response rates to requests for laboratory records by facilities in which staphylococcal deaths occurred in Texas, Response Adequate information77 (68.2)114 (51.2) No culture reports12 (10.6)40 (17.9) No response24 (21.2)69 (30.9) Total113 (100)223 (100) 2 Medical records requested on 210 deaths Number ( %) 1 Medical records requested on sample of 197 total deaths
2004 RaceMRSA # (%) MSSA # (%) White †39 (67.2)19 (37.8) Black5 (71.4)2 (28.6) Other8 (66.7)4 (33.3) Race/Ethnicity † Reference group
Culture sources of staphylococcal infections resulting in death in Texas, Culture Source Blood 53 (68.8)51 (44.7) Sputum 11 (14.3)36 (31.6) Bronchial Wash 3 (3.9)7 (6.1) Respiratory 3 (3.9)5 (4.4) Catheter Tip 2 (2.6)0 (0.0) Skin 1 (1.3)0 (0.0) Spinal fluid 2 (2.6)0 (0.0) Wound 1 (1.3)10 (8.8) Urine 0 (0.0)4 (3.5) Arterial Line 0 (0.0)1 (0.9) Not Listed 1 (1.3)0 (0.0) Total 77 (100)114 (100) 2 Medical records requested on 210 deaths Number ( %) 1 Medical records requested on sample from 197 deaths
Number of deaths per year reporting staphylococcus as a contributing COD
Number of deaths per year reporting staphylococcus as the underlying COD
Staphylococcal species responsible for infections resulting in death in Texas,
Demographic variables associated with deaths due to MRSA compared with deaths due to MSSA Sex MRSA # (%) MSSA # (%) MRSA # (%) MSSA # (%) Male † 33 (64.7)18 (35.3)50 (80.6)12 (19.4) Female 19 (73.9) 733 (73.3)12 (26.7) † Reference group
Demographic variables associated with deaths due to MRSA compared with deaths due to MSSA AgeMRSA # (%) MSSA # (%) MRSA # (%) MSSA # (%) Mean Age ≥ 30 † 5(55.6) 4(44.4) 6(85.7) 1(14.3) (69.6) 7(30.4)18(85.7) 3(14.3) > 60 31(68.9)14(31.1)59(74.7)20(25.3) † Reference Group
Association of site of staphylococcal infection with MRSA compared with MSSA
Percent antibiotic resistance of staphylococcal species as reported on susceptibility tests for persons dying of staphylococcal infections in Texas, *Data are based on hospital laboratory reports. No vancomycin resistant staphylococcus have been confirmed in Texas.
Antibiotic Classification
Percent antibiotic class resistance of staphylococcal species as reported on susceptibility tests for persons dying of staphylococcal infections in Texas,
2005 Texas Population and Staph Death Count
2005 Texas Population and Staph Death Rate (per 100,000)
2005 Texas Population and Staphylococcal Death (Per 100,000)
Staphylococcal Death Count and Rate (per 100,000)
Rural Urban Continuum Code by Staph Death Count
RUC Code and Staph Death Rate (per 100,000)
Staphylococcal Death by Rural-Urban Continuum Code (Per 100,000)
Special Thanks to J. Charles Huber Jr, PhD Asst. Professor of Biostatistics Dept. of Epidemiology and Biostatistics Texas A&M Health Science Center School of Public Health